Timezone: US/Eastern

Last Price Update:
2019-09-05 06:10:54



Ex-Dividend Calendar



Common Stock Sectors



Collections



Bristol-Myers Squibb Company

Symbol: BMY     Sector: Healthcare     Industry: Drug Manufacturers

Dividend Yield
3.70%
Current Price
$44.33
Info     Dividend Rate History     Earnings     Financials     Rankings

Financials 2019

Update: 2019-06-11 03:40:02

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 1

2019-03-31
5,713,000,000
5,920,000,000
1,844,000,000
4,076,000,000
2,357,000,000
1,719,000,000
1,710,000,000
17,093,000,000
34,834,000,000
19,517,000,000
15,218,000,000
7,335,000,000
381,000,000
8,764,000,000
6,016,000,000
421,000,000
1,390,000,000
 
1,351,000,000

Financials 2018

Update: 2019-06-11 03:40:02

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 4

2018-12-31
5,715,000,000
5,973,000,000
1,690,000,000
4,283,000,000
2,716,000,000
1,567,000,000
1,160,000,000
17,160,000,000
34,986,000,000
20,859,000,000
14,031,000,000
6,911,000,000
1,703,000,000
8,884,000,000
7,349,000,000
1,515,000,000
2,429,000,000
 
1,380,000,000

Q 3

2018-09-30
5,433,000,000
5,691,000,000
1,648,000,000
4,043,000,000
2,384,000,000
1,659,000,000
1,901,000,000
14,869,000,000
33,734,000,000
19,984,000,000
13,640,000,000
5,408,000,000
1,620,000,000
6,830,000,000
7,307,000,000
412,000,000
1,279,000,000
 
1,280,000,000

Q 2

2018-06-30
5,461,000,000
5,704,000,000
1,625,000,000
4,079,000,000
3,566,000,000
513,000,000
373,000,000
13,874,000,000
32,641,000,000
20,223,000,000
12,317,000,000
4,999,000,000
1,716,000,000
6,075,000,000
7,387,000,000
-306,000,000
1,057,000,000
 
2,435,000,000

Q 1

2018-03-31
4,972,000,000
5,193,000,000
1,584,000,000
3,609,000,000
2,219,000,000
1,390,000,000
1,486,000,000
14,649,000,000
33,083,000,000
20,177,000,000
12,793,000,000
5,342,000,000
1,925,000,000
6,770,000,000
7,700,000,000
-90,000,000
1,175,000,000
 
1,250,000,000

Financials 2017

Update: 2019-06-11 03:40:02

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 4

2017-12-31
5,046,000,000
5,449,000,000
1,653,000,000
3,796,000,000
3,311,000,000
485,000,000
-2,328,000,000
14,854,000,000
33,551,000,000
21,704,000,000
11,741,000,000
5,421,000,000
987,000,000
6,812,000,000
7,962,000,000
784,000,000
1,117,000,000
 
1,868,000,000